Fort Collins, CO, United States of America

Nicole Marquardt

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Tolmar International Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicole Marquardt. Retrieved from https://idiyas.com/inventor/nicole-marquardt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicole Marquardt: Inventor of a Polymeric Leuprolide Acetate Formulation

Introduction

Nicole Marquardt is an inventor based in Fort Collins, Colorado, whose patent work concerns pharmaceutical formulations. Her listed invention addresses ways to formulate and use leuprolide acetate, a medication used in medical treatment.

Latest Patents

Marquardt is associated with 1 patent, titled “Polymeric Leuprolide Acetate Formulations.” The patent describes liquid-liquid formulations of leuprolide acetate comprising a biodegradable polymer and a biocompatible solvent, along with methods for using those formulations.

Career Highlights

Marquardt is associated with Tolmar International Limited. Her patent reflects work on polymer-based drug formulations and their potential applications.

Collaborations

Her listed coworkers include Dileep Janagam and David Dummer. Their names appear alongside Marquardt in connection with the patent information provided.

Conclusion

Nicole Marquardt’s patent work focuses on a polymeric leuprolide acetate formulation and methods for its use, highlighting her contribution to pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…